The Open Meeting will be held as a hybrid event, with delegates on-site and others viewing the talks remotely. Virtual and in-person delegates will all have the opportunity to contribute to the Q&A session following each talk.
The first participants have been recruited in Oxford for a new multinational clinical trial that will investigate whether a novel treatment can help slow the progression of chronic kidney disease (CKD).
Read more here.
Leeds Teaching Hospitals NHS Trust (LTHT) is piloting an AI solution, designed by Lucida Medical, to assess whether it can improve prostate cancer diagnosis.
Read the full article here.